Displaying 861 - 880 of 1516
ProMedica Health System, Inc., FTC and State of Ohio v.
Laboratory Corporation of America and Laboratory Corporation of America Holdings
FTC Denies North Carolina Dental Board's Motion to Dismiss Allegations That it Stifled Competition for Teeth-Whitening Services
FTC and Ohio Attorney General Challenge ProMedica's Acquisition of St. Luke's Hospital
Minnesota Rural Health Cooperative, In the Matter of
The Minnesota Rural Health Cooperative (MRHC), comprised by a group of doctors and hospitals in southwestern Minnesota, agreed to a settlement with the Federal Trade Commission that prohibits anticompetitive tactics the group allegedly used to increase health insurance reimbursement rates. The MRHC is made up of approximately 25 hospitals and 70 doctors, representing most of the hospitals and half of the primary care physicians in southwestern Minnesota. According to the FTC’s complaint, when members join the MRHC, they agree that the group’s board of directors will negotiate and contract with health insurers on their behalf and that they will abide by the MRHC contracts. The settlement order bars the MRHC from using coercive tactics to extract favorable contract terms from health plans. In addition, the order requires the MRHC to offer to renegotiate all current contracts with health plans and to submit any revised contracts for state approval.
Bisaro, Paul
Prepared Statement of the Federal Trade Commission on Antitrust Enforcement in the Health Care Industry
FTC Challenges LabCorp's Acquisition of Rival Clinical Laboratory Testing Company
FTC Testifies on Antitrust Enforcement in the Health Care Industry
FTC Requires Universal Health Services to Sell 15 Psychiatric Facilities as a Condition of Acquiring Rival Psychiatric Solutions
Promedica Health System, Inc.
Workshop Regarding Accountable Care Organizations and Implications Regarding Antitrust, Physican Self-Referral, Anti-Kickback and Civil Monetary Penalty (CMP) Laws
Novartis AG, In the Matter of (Alcon, Inc)
To settle FTC charges that its proposed acquisition of Alcon, Inc., would be anticompetitive, Novartis AG agreed to sell an injectable eye care drug used in cataract surgery. Novartis and Alcon are the only two U.S. providers of the class of drugs known as injectable miotics, and the FTC alleges that the acquisition would have created a monopoly in injectable miotics. The settlement requires Novartis to sell its drug Miochol-E to Bausch & Lomb, Inc.
FTC, HHS Office of Inspector General, and Centers for Medicare & Medicaid Services Announce Workshop on Issues Related to Accountable Care Organizations
FTC Staff Opinion: Yakima Valley Memorial Hospital's Proposed Rx Program Exempt From the Robinson-Patman Act
Court Orders Internet Marketers of Acai Berry Weight-Loss Pills and "Colon Cleansers" to Stop Deceptive Advertising and Unfair Billing Practices
Carilion Clinic, a corporation, In the Matter of
The Commission issued an administrative complaint challenging Carilion Clinic’s 2008 acquisition of two competing outpatient clinics in the Roanoke, Virginia, area. The complaint alleges that Carilion’s acquisition of these outpatient centers eliminated competition for patients in the Roanoke area. On October 7, 2009 Carillion agreed to sell two independent outpatient medical clinics it acquired last year to settle the charges.
FTC Staff Opinion: Community CarePartners, Inc.'s Proposed Discount Rx Program Exempt From the Robinson-Patman Act
Displaying 861 - 880 of 1516